Kidney Research and Clinical Practice

Search

Page Path

HOME
Search

Original Articles

Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): final report: Hayne Cho Park, Yong Chul Kim, Hyunsuk Kim et al.; Received March 10, 2024 Accepted June 7, 2024 Published online September 11, 2024; [Epub ahead of print]; Full text PubReader ePub PDF Supplementary Material

Baseline characteristics of the Korean genetic cohort of inherited cystic kidney disease: Jeong Min Cho, Hayne Cho Park, Jin Woo Lee et al.; Kidney Res Clin Pract. 2023;42(5):617-627. Published online September 27, 2023; DOI: https://doi.org/10.23876/j.krcp.23.097
Web of Science 1 Cited By 1; Full text PubReader ePub PDF Supplementary Material

Identification of osteopontin as a urinary biomarker for autosomal dominant polycystic kidney disease progression: Hyunsuk Kim, Jinmo Sung, Ju Young Bae, Poongyeon Lee, Yun Kyu Oh, Hyunho Kim; Kidney Res Clin Pract. 2022;41(6):730-740. Published online June 20, 2022; DOI: https://doi.org/10.23876/j.krcp.21.303
Web of Science 6 Cited By 7; Full text PubReader ePub PDF

Review Articles

Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options: Yeshwanter Radhakrishnan, Parikshit Duriseti, Fouad T. Chebib; Kidney Res Clin Pract. 2022;41(4):422-431. Published online March 29, 2022; DOI: https://doi.org/10.23876/j.krcp.21.309
Web of Science 9 Cited By 11; Full text PubReader ePub PDF

Original Articles

Mayo imaging classification is a good predictor of rapid progress among Korean patients with autosomal dominant polycystic kidney disease: results from the KNOW-CKD study: Hayne Cho Park, Yeji Hong, Jeong-Heum Yeon et al.; Kidney Res Clin Pract. 2022;41(4):432-441. Published online March 3, 2022; DOI: https://doi.org/10.23876/j.krcp.21.261
Web of Science 6 Cited By 8; Full text PubReader ePub PDF Supplementary Material

Comparison of chronic kidney disease trial designs and analysis strategies: John Lawrence; Kidney Res Clin Pract. 2021;40(1):62-68. Published online March 5, 2021; DOI: https://doi.org/10.23876/j.krcp.20.104
Web of Science 1 Cited By 1; Full text PubReader ePub PDF Supplementary Material

PKD2 mutation in an Iranian autosomal dominant polycystic kidney disease family with misleading linkage analysis data^☆: Mona Entezam, Mohammad Reza Khatami, Fereshteh Saddadi, Mohsen Ayati, Jamshid Roozbeh, Mohammad Keramatipour; Kidney Res Clin Pract. 2016;35(2):96-101. Published online February 27, 2016; DOI: https://doi.org/10.1016/j.krcp.2016.02.003
Web of Science 1 Cited By 1; Full text PubReader PDF

Review Article

Cyst growth, polycystins, and primary cilia in autosomal dominant polycystic kidney disease: Seung Hun Lee, Stefan Somlo; Kidney Res Clin Pract. 2014;33(2):73-78. Published online June 14, 2014; DOI: https://doi.org/10.1016/j.krcp.2014.05.002
Web of Science 37 Cited By 33; Full text PubReader PDF

A Case of Spontaneous Subdural Hematoma in a Patient with Autosomal Dominant Polycystic Kidney Disease: Won Ik Jang, M.D., Young Rok Ham, M.D., Ji Yoon Jung, M.D., Dong Suk Chang, M.D., Sarah Chung, M.D., Dae Eun Choi, M.D., Ki Ryang Na, M.D., Kang Wook Lee, M.D. and Young Tai Shin, M.D.; Korean J Nephrol. 2010;29(6):802-806.; PDF

Tuberous Sclerosis Manifested by Spontaneous Rupture of Renal Angiomyolipoma in a Patient with Polycystic Kidney Disease: Tae-Woo Kim, M.D. Sook Kim, M.D. , Seung Boo Yang, M.D. Chu Hee Lee, Ph.D. Jun Young Do, M.D. Jong Won Park, M.D.; Korean J Nephrol. 2007;26(6):772-778.; PDF

Volume 43, No. 6

Kidney Research
and
Clinical Practice

Print ISSN: 2211-9132
Online ISSN: 2211-9140

Impact Factor

2.9

MOST VIEWED MOST CITED

4,187	Artificial intelligence and machine learning’s role in sepsis-associated acute kidney injury
3,359	Personalized nutritional management in the transition from non-dialysis dependent chronic kidney disease to dialysis
12,389	How should we treat acute kidney injury caused by renal congestion?
3,283	Biomarkers in pursuit of precision medicine for acute kidney injury: hard to get rid of customs
3,834	Unveiling the enigma of acute kidney disease: predicting prognosis, exploring interventions, and embracing a multidisciplinary approach

Cited By 19	Uremic pruritus: pathophysiology, clinical presentation, and treatments
Cited By 17	Deep learning predicts the differentiation of kidney organoids derived from human induced pluripotent stem cells
Cited By 14	The flavonoid fisetin ameliorates renal fibrosis by inhibiting SMAD3 phosphorylation, oxidative damage, and inflammation in ureteral obstructed kidney in mice
Cited By 13	Acute kidney disease: an overview of the epidemiology, pathophysiology, and management
Cited By 12	An update on renal fibrosis: from mechanisms to therapeutic strategies with a focus on extracellular vesicles

Editorial Office: #301, (Miseung Bldg.) 23, Apgujenog-ro 30-gil, Gangnam-gu, Seoul 06022, Korea
Tel: +82-2-3486-8736 Fax: +82-2-3486-8737 E-mail: registry@ksn.or.kr

Copyright © 2025 by The Korean Society of Nephrology.